The smallpox treatment market deals with products and therapies related to treatment of smallpox disease. Some key products include vaccines, antiviral drugs, monoclonal antibody therapeutics etc. These products are used to either prevent or treat smallpox infections.

Market Dynamics:

Increasing research funding for development of novel smallpox therapeutics is expected to drive the market growth. Government and private organizations are increasingly funding research programs focused on developing targeted smallpox therapies. For instance, National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health (NIH), provides funding for research on new smallpox vaccines and antiviral drugs through various grants. Additionally, increasing usage of monoclonal antibodies for treatment of various infectious diseases is also projected to aid in market expansion over the forecast period. Monoclonal antibody therapeutics offer highly targeted treatment response against smallpox viruses.

The Global Smallpox Treatment Market Size is expected to witness high growth, exhibiting CAGR of 1.8% over the forecast period, due to increasing threat of bioterrorism and accidental outbreaks. The market was valued at US$ 68.7 Mn in 2023.

North America dominated the global market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to growing R&D investments by key players, rising government support for product development, and strong prevention measures in the region against bioterrorism threats. Asia Pacific is anticipated to witness the fastest growth during the analysis period driven by rising biodefense initiatives and economic development in major countries like India and China.

Read More

https://healthcarelatesteditionnews.blogspot.com/2023/11/vaccine-segment-is-largest-segment.html